Hememics Biotechnologies develops graphene-based biosensors and antibody-screening systems, including its FAST™ reader and disposable multiplexed chips that assess antibody–antigen binding in less than an hour. Based in Gaithersburg, Maryland, the company also develops HemChip® platforms for portable, simultaneous detection of biological and chemical targets. Its founding team combines blood-platelet research with experience engineering graphene sensor hardware and software.
IdentifySensors BiologicsCleveland-based IdentifySensors Biologics is developing Check4, a portable digital diagnostic platform that uses graphene-based printed biosensors to detect infectious pathogens and cancer biomarkers from saliva or blood. Founded by trauma surgeon and former NASA medical consultant Greg Hummer and data scientist Matthew Hummer, the company connects its electronic tests to cloud-based analysis rather than relying on conventional laboratory workflows. Its products remain under development and are not yet approved for sale.SHAKER HEIGHTS, OH
Advanced Biomimetic Sensors, IncFounded in 2006 by CEO Ellen T. Chen, Ph.D., Bethesda-based Advanced Biomimetic Sensors is a woman-owned small business developing medical diagnostic and monitoring devices built around nanobiomimetic, reagent-free sensing. Its work includes handheld systems for triple-negative breast cancer monitoring and blood-glucose testing, alongside the patented QSensing® platform for detecting proteins in human serum. The company’s technology has received National Innovation Awards in 2017 and 2018 and a National Defense Innovation Award in 2022.BETHESDA, MD
Scanogen IncBaltimore-based Scanogen develops molecular diagnostic systems that detect infectious-disease biomolecules directly from body fluids, using its proprietary Single Molecule And Rapid Tethering (SMART) technology. The company is focused on a sample-to-answer platform for point-of-care testing, including an assay designed to identify bloodstream-infection pathogens from whole blood within two hours. Scanogen has received more than $20 million in NIH grants and collaborates with Johns Hopkins University and federal agencies in the Washington, D.C., area.BALTIMORE, MD
AptaMatrix, IncHeadquartered in Syracuse, AptaMatrix is a privately held biotechnology company developing next-generation sequencing-based methods to accelerate the discovery of aptamers—DNA or RNA molecules that can support diagnostic and biosensor applications. Its patented Acyclic Identification of Aptamers (AIA) and multiplexed AIA approaches grew from research and industry partnerships at Syracuse University, with the company applying them to disease detection and its AP3 assay platform. AptaMatrix also developed AlloSwitch sensors for near-real-time detection of biological targets.SYRACUSE, NY